Nuwellis (NUWE) Net Income towards Common Stockholders (QoQ) (2011 - 2026)
Nuwellis (NUWE) Net Income towards Common Stockholders (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Nuwellis | 203,898.38 | -3.72 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.35% |
| Mar 31, 2026 | -87.48% |
| Dec 31, 2025 | -616.20% |
| Sep 30, 2025 | 103.74% |
| Jun 30, 2025 | -316.59% |
| Mar 31, 2025 | -105.25% |
| Dec 31, 2024 | -162.26% |
| Sep 30, 2024 | 130.52% |
| Jun 30, 2024 | -103.88% |
| Mar 31, 2024 | 52.20% |
| Dec 31, 2023 | -135.22% |
| Sep 30, 2023 | 30.44% |
| Jun 30, 2023 | 25.29% |
| Mar 31, 2023 | -371.98% |
| Dec 31, 2022 | 64.50% |
| Sep 30, 2022 | 9.71% |
| Jun 30, 2022 | 4.18% |
| Mar 31, 2022 | -128.27% |
| Dec 31, 2021 | 400.09% |
| Sep 30, 2021 | -11.44% |